GPP

Great Point Partners Portfolio holdings

AUM $154M
This Quarter Return
-4.37%
1 Year Return
-2.36%
3 Year Return
+169.3%
5 Year Return
+292.82%
10 Year Return
+3,519.88%
AUM
$447M
AUM Growth
+$447M
Cap. Flow
-$6.87M
Cap. Flow %
-1.54%
Top 10 Hldgs %
59.14%
Holding
40
New
10
Increased
10
Reduced
5
Closed
10

Top Buys

1
FOLD icon
Amicus Therapeutics
FOLD
$15.4M
2
DYN icon
Dyne Therapeutics
DYN
$14.2M
3
RPTX icon
Repare Therapeutics
RPTX
$13.6M
4
DNTH icon
Dianthus Therapeutics
DNTH
$10.9M
5
KURA icon
Kura Oncology
KURA
$10.4M

Top Sells

1
IOVA icon
Iovance Biotherapeutics
IOVA
$29.4M
2
CNST
Constellation Pharmaceuticals, Inc.
CNST
$20.4M
3
BIIB icon
Biogen
BIIB
$14.7M
4
LNTH icon
Lantheus
LNTH
$13.9M
5
NVRO
NEVRO CORP.
NVRO
$11.2M

Sector Composition

1 Healthcare 97.32%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
CTMX icon
26
CytomX Therapeutics
CTMX
$350M
$6.33M 1.33%
+1,000,000
New +$6.33M
SYRE icon
27
Spyre Therapeutics
SYRE
$1.02B
$6.26M 1.31%
900,000
+397,100
+79% +$2.76M
VERV
28
DELISTED
Verve Therapeutics
VERV
$2.11M 0.44%
+35,000
New +$2.11M
ACAD icon
29
Acadia Pharmaceuticals
ACAD
$4.34B
– –
-311,217
Closed -$8.03M
FGEN icon
30
FibroGen
FGEN
$48.4M
– –
0
– –
GERN icon
31
Geron
GERN
$893M
– –
-2,610,000
Closed -$4.12M
IOVA icon
32
Iovance Biotherapeutics
IOVA
$800M
– –
-930,000
Closed -$29.4M
LNTH icon
33
Lantheus
LNTH
$3.75B
– –
-649,516
Closed -$13.9M
LUNG icon
34
Pulmonx
LUNG
$67.6M
– –
-114,345
Closed -$5.23M
NTLA icon
35
Intellia Therapeutics
NTLA
$1.26B
– –
0
– –
RDHL
36
Redhill Biopharma
RDHL
$2.94M
– –
-705,305
Closed -$5.16M
YMAB icon
37
Y-mAbs Therapeutics
YMAB
$390M
– –
-150,000
Closed -$4.54M
NVRO
38
DELISTED
NEVRO CORP.
NVRO
– –
-80,000
Closed -$11.2M
RXDX
39
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
– –
-250,000
Closed -$4.57M
CNST
40
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
– –
-872,415
Closed -$20.4M
1
2